DOLUTEGRAVIR SODIUM Intermediates CAS No 1246616-73-8 Pharmaceutical Intermediates

Product Name	DOLUTEGRAVIR SODIUM Intermediates
Other Name	(S)-7-HYDROXY-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXYLIC ACID
CAS No.	1246616-73-8
EINECS	/
Formula	C13H14N2O6
Molecular Weight	294.26
Appearance	White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

- High Purity and Quality: (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid is produced under strict quality controls to ensure high purity levels for pharmaceutical applications.
- Multiple Drug Applications: This compound is critical for the development of a variety of therapeutic agents, particularly in the areas of oncology and infectious diseases.
- Integrated Production and Trading: As a production and trading integrated factory, we provide a seamless supply chain from manufacturing to delivery.
- Regulatory Compliance: Our products comply with all necessary industry regulations and standards, ensuring customer safety and reliability.
- Expertise and Experience: With many years of experience in the pharmaceutical industry, we are committed to quality and customer satisfaction.

product details

Product details

introduce

Overview of (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid is a complex organic compound that plays an important role in the pharmaceutical industry. This compound is primarily used in the synthesis of various therapeutic agents, particularly those targeting cancer and infectious diseases. Our (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid is manufactured in state-of-the-art facilities, ensuring that every batch meets the highest quality and efficacy standards.

Physical and chemical properties

- Molecular formula: C13H14N2O6
- Molecular weight: 294.26 g/mol
- Appearance: White solid.
- Solubility: Soluble in organic solvents, moderately solubility in water, providing formulation flexibility.
- Stability: The compound exhibits good stability under standard storage conditions, which is critical to maintaining the integrity of the drug product.

advantage

- Enhanced therapeutic effects: Such compounds are critical for the development of drugs that target specific pathways in cancer and infectious diseases, enhancing the overall therapeutic effect of the formulation.
- Quality Control: The high purity of (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid ensures pharmaceutical companies can maintain strict quality control standards and reduce the risk of impurities in the final product.
- Regulatory Compliance: The compound meets all necessary regulatory requirements, which helps to make the approval process of the new drug application smoother.
- Multiple Applications: Its unique chemical structure makes it widely applicable in drug development and is a valuable asset for drug researchers and manufacturers.
- Expert Support: Our experienced team can provide technical support and guidance on the use of (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid in various formulations to ensure the best results for our customers.

Uses in the pharmaceutical industry

In conclusion,(S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid is an important compound for pharmaceutical manufacturers to develop innovative therapeutic drugs. It is a key ingredient in the pharmaceutical industry due to its excellent physical and chemical properties, recognized role in enhancing drug efficacy, and regulatory compliance. Partner with us to improve the quality of your drug products and meet the growing market demand for high-quality compounds. Contact us today to learn more about (S)-7-Hydroxy-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxylic acid and how we can support your business needs.